Trpti™ is OEA powered by LipiSperse® technology by Pharmako Biotechnologies Pty Ltd.
Oleoylethanolamide (OEA) is a fatty acid amide produced by the body that signals to our brain that we are full. OEA binds to GPR-119 to produce GLP-1 in the bodyʼs intestines naturally and is essential for the bodyʼs homeostasis and metabolic function. It acts on inflammation, but also offers satiety, fat management, lipid management, glucose control, body mass, body weight, BMI, and body fat.
The LipiSperse® in Trpti™ shepherds OEA through the GI tract and delivers OEA efficiently to the intestines, where it best enhances the production of the bodyʼsown GLP-1. This ensures no side effects, unlike the synthetic GLP-1 agonists, which have a myriad of side effects.
Download Sales Sheet